REMEGEN (09995) is recommended to adopt the A-share stock incentive plan in 2023.
Connect global capital markets
REMEGEN (09995) announced that the board of directors recommends adopting the 2023 A-share stock incentive plan, planning to grant approximately 1.7831 million restricted stocks to the incentive beneficiaries. Upon the initial grant, 1.43245 million restricted stocks will be allocated, and approximately 0.3506 million restricted stocks will be reserved. The grant price (including reserved grants) is set at RMB 49.77 per A-share.
Related Articles

Goldman Sachs' Global Stock Market Outlook for 2026: A Broader Bull Market, a Wider Range of AI Beneficiaries.

"AI's new favorite" Behind Carter's Incorporated's (CAT.US) darkest 5-day price drop: AI narrative enters a period of intense volatility

The success or failure of OpenAI's fundraising will determine the fate of the entire data center industry.
Goldman Sachs' Global Stock Market Outlook for 2026: A Broader Bull Market, a Wider Range of AI Beneficiaries.

"AI's new favorite" Behind Carter's Incorporated's (CAT.US) darkest 5-day price drop: AI narrative enters a period of intense volatility

The success or failure of OpenAI's fundraising will determine the fate of the entire data center industry.






